Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,469 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
Hart RG, Sharma M, Mundl H, Kasner SE, Bangdiwala SI, Berkowitz SD, Swaminathan B, Lavados P, Wang Y, Wang Y, Davalos A, Shamalov N, Mikulik R, Cunha L, Lindgren A, Arauz A, Lang W, Czlonkowska A, Eckstein J, Gagliardi RJ, Amarenco P, Ameriso SF, Tatlisumak T, Veltkamp R, Hankey GJ, Toni D, Bereczki D, Uchiyama S, Ntaios G, Yoon BW, Brouns R, Endres M, Muir KW, Bornstein N, Ozturk S, O'Donnell MJ, De Vries Basson MM, Pare G, Pater C, Kirsch B, Sheridan P, Peters G, Weitz JI, Peacock WF, Shoamanesh A, Benavente OR, Joyner C, Themeles E, Connolly SJ; NAVIGATE ESUS Investigators. Hart RG, et al. Among authors: lang w. N Engl J Med. 2018 Jun 7;378(23):2191-2201. doi: 10.1056/NEJMoa1802686. Epub 2018 May 16. N Engl J Med. 2018. PMID: 29766772 Free article. Clinical Trial.
Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, Hennerici MG, Mattle HP, Rothwell PM; PERFORM Study Investigators. Bousser MG, et al. Cerebrovasc Dis. 2009;27(5):509-18. doi: 10.1159/000212671. Epub 2009 Apr 16. Cerebrovasc Dis. 2009. PMID: 19372653 Free article. Clinical Trial.
Clinical predictors of death in young and middle-aged patients with ischemic stroke or transient ischemic attack: long-term results of the Vienna Stroke Registry: clinical predictors of ischemic stroke mortality in patients <60 years.
Greisenegger S, Zehetmayer S, Ferrari J, Lang W, Fizek J, Auff E, Lalouschek W, Serles W. Greisenegger S, et al. Among authors: lang w. J Neurol. 2011 Jun;258(6):1105-13. doi: 10.1007/s00415-010-5893-9. Epub 2011 Feb 1. J Neurol. 2011. PMID: 21286745
IV thrombolysis in patients with ischemic stroke and alcohol abuse.
Gattringer T, Enzinger C, Fischer R, Seyfang L, Niederkorn K, Khalil M, Ferrari J, Lang W, Brainin M, Willeit J, Fazekas F. Gattringer T, et al. Among authors: lang w. Neurology. 2015 Nov 3;85(18):1592-7. doi: 10.1212/WNL.0000000000002078. Epub 2015 Oct 7. Neurology. 2015. PMID: 26446065
Predictive value of ABCD2 and ABCD3-I scores in TIA and minor stroke in the stroke unit setting.
Knoflach M, Lang W, Seyfang L, Fertl E, Oberndorfer S, Daniel G, Seifert-Held T, Brainin M, Krebs S, Matosevic B, Töll T, Kiechl S, Willeit J, Ferrari J; Austrian Stroke Unit Collaborators. Knoflach M, et al. Among authors: lang w. Neurology. 2016 Aug 30;87(9):861-9. doi: 10.1212/WNL.0000000000003033. Epub 2016 Jul 29. Neurology. 2016. PMID: 27473138
1,469 results